Inhibitor profiling of the Pseudomonas aeruginosa virulence factor LasB using N-alpha mercaptoamide template-based inhibitors


Autoria(s): Cathcart, George; Gilmore, Brendan; Greer, Brett; Harriott, Patrick; Walker, Brian
Data(s)

01/11/2009

Resumo

We report on the synthesis and biological evaluation of a focussed library of N-alpha mercaptoamide containing dipeptides as inhibitors of the zinc metallopeptidase Pseudomonas aeruginosa elastase (LasB, EC 3.4.24.26). The aim of the study was to derive an inhibitor profile for LasB with regard to mapping the S´1 binding site of the enzyme. Consequently, a focussed library of 160 members has been synthesised, using standard Fmoc-solid phase methods (on a Rink-amide resin), in which a subset of amino acids including examples of those with basic (Lys, Arg), aromatic (Phe, Trp), large aliphatic (Val, Leu) and acidic (Asp, Glu) side-chains populated the P´2 position of the inhibitor sequence and all 20 natural amino acids were incorporated, in turn, at the P´1 position. The study has revealed a preference for aromatic and/or large aliphatic amino acids at P´1 and a distinct bias against acidic residues at P´2. Ten inhibitor sequences were discovered that exhibited sub to low micromolar Ki values.

Identificador

http://pure.qub.ac.uk/portal/en/publications/inhibitor-profiling-of-the-pseudomonas-aeruginosa-virulence-factor-lasb-using-nalpha-mercaptoamide-templatebased-inhibitors(546bc496-2bd7-477e-91b9-bb6f42f56f52).html

http://dx.doi.org/10.1016/j.bmcl.2009.08.099

http://www.scopus.com/inward/record.url?scp=71749100910&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Cathcart , G , Gilmore , B , Greer , B , Harriott , P & Walker , B 2009 , ' Inhibitor profiling of the Pseudomonas aeruginosa virulence factor LasB using N-alpha mercaptoamide template-based inhibitors ' Bioorganic & Medicinal Chemistry Letters , vol 19 , no. 21 , pp. 6230-6232 . DOI: 10.1016/j.bmcl.2009.08.099

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1303 #Biochemistry #/dk/atira/pure/subjectarea/asjc/1300/1308 #Clinical Biochemistry #/dk/atira/pure/subjectarea/asjc/1300/1312 #Molecular Biology #/dk/atira/pure/subjectarea/asjc/1300/1313 #Molecular Medicine #/dk/atira/pure/subjectarea/asjc/1600/1605 #Organic Chemistry #/dk/atira/pure/subjectarea/asjc/3000/3002 #Drug Discovery #/dk/atira/pure/subjectarea/asjc/3000/3003 #Pharmaceutical Science
Tipo

article